Side-by-side comparison of AI visibility scores, market position, and capabilities
Proscia provides a digital pathology platform (Concentriq) that digitizes glass slide workflows and applies AI to accelerate and improve cancer diagnosis; raised $37M including a $25M Series B; FDA-cleared AI applications;
Proscia is a Philadelphia-based health technology company founded in 2014 that has developed a digital and computational pathology platform — called Concentriq — designed to transform how pathologists diagnose cancer and how pharmaceutical companies conduct drug discovery research. Pathology has historically been one of the last medical specialties to transition from analog to digital workflows: the standard of care still involves pathologists examining glass microscope slides by hand under optical microscopes. Proscia's Concentriq platform digitizes these glass slides using whole-slide imaging scanners, stores the resulting high-resolution digital images in a cloud-based repository, and provides pathologists with an AI-augmented viewer that can highlight diagnostic features, flag regions of interest, and assist with quantitative analysis that would be time-consuming or impossible to perform manually.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.